Allobaculum stercoricanis and Its Postbiotics Alleviate Dextran Sulfate Sodium (DSS)-Induced Colitis through the Regulation of theTLR4/NF-κB Signaling Pathway.
Oct 2026· Journal of Agricultural and Food Chemistry· Vol 74 43, pp.
33790-33804
· 0 citations· 50 references
Medicine
TL;DR
It is demonstrated that live Allobaculum stercoricanis and its two postbiotic preparations and its two postbiotic preparationseffectively alleviated dextran sulfate sodium (DSS)-induced colitis in mice, and hypothesize that α-MCA may contribute to ameliorating intestinal inflammation through engagement of FXR and suppression of the TLR4/NF-κB signaling pathway.
Abstract
Inflammatory bowel disease (IBD) is a chronic intestinal disorder that has become a global public health concern. Postbiotics offer advantages in biosafety and reproducibility over probiotics. Here, we demonstrated that live Allobaculum stercoricanis (A. stercoricanis) and its two postbiotic preparations─inactivated bacterial cells (POST) and cell-free fermentation supernatant (CFS)─effectively alleviated dextran sulfate sodium (DSS)-induced colitis in mice. Integrated gut microbiome and serum metabolomics analyses indicated that these interventions may act through modulating bile acid metabolism and Toll-like receptor signaling pathways. Further investigations combining postbiotic metabolomics, network pharmacology, molecular docking, and molecular dynamics simulations identified α-muricholic acid (α-MCA) as a candidate functional metabolite, with the farnesoid X receptor (FXR) as a potential target. We hypothesize that α-MCA may contribute to ameliorating intestinal inflammation through engagement of FXR and suppression of the TLR4/NF-κB signaling pathway. These findings provide new insights into postbiotic-based therapeutic strategies for IBD.
It is demonstrated that Pa JY062 ameliorates DSS-induced colitis by upregulating miR-6974-5p, which directly targets IL-17A and suppresses the downstream MAPK/AP-1 signaling pathway, revealing a novel miRNA-dependent mechanism that provides a scientific basis for developing functional foods and miRNA-targeted therapies...
Jin-Feng Guo, Yun-Lei Chai, Kai-Qi Gao et al.· Food Science and Human Welln...· 0 citations
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with limited therapeutic options, and the contribution of microbiota-associated metabolites to disease progression remains incompletely understood. Here, we demonstrate that Forsythia polysaccharides (FPs) exert protective effects against dextran sulfa...
Peng Cheng, Ying Huang, Yi-Xiang Luo et al.· International Journal of Bio...· 0 citations
ABSTRACT Gut microbiota dysbiosis is increasingly recognized as a modifiable determinant of sepsis susceptibility and outcomes, yet protective commensals and microbiota-associated metabolites with actionable host mechanisms remain incompletely defined. Here, fecal 16S rRNA sequencing of septic and non-septic patients r...
Hong Wang, Ao-Lin Jiang, Yi He et al.· mSystems· 0 citations
Ulcerative colitis (UC) is a chronic inflammatory bowel disease featured by impaired colonic mucus barrier dominated by MUC2. Dietary polysaccharides alleviate UC mainly via gut microbiota fermentation, but their direct effects on goblet cells remain unclear. Here, we identified a low-molecular-weight (2.68 kDa) in...
Yi-Mu Ma, Zhi-Hua Wang, Ya-Qi Tong et al.· Food Science and Human Welln...· 0 citations
It is found that F1m enhances AzA production by modulating gut microbiota, thereby protecting against colitis via PPARγ activation, and indicates that F1m enhances AzA production by modulating gut microbiota, thereby protecting against colitis via PPARγ activation.
Dan Jia, Yuan Han, Zhi Li et al.· Journal of Agricultural and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.